Press Releases

08/02/2018 - Pixium Vision announces its 2017 annual results and provides business update

• The PRIMA system successfully elicited light perception, now in the first two AMD patients
• US FDA approved early feasibility study with PRIMA in atrophic dry-AMD
• Growth strategy focus on the development of PRIMA in AMD, a significant unmet medical need

25/01/2018 - Pixium Vision completes World's First Successful Activation in Human of PRIMA Bionic Vision System

PRIMA, miniaturized wireless photovoltaic sub-retinal implant, elicited visual perception in the first human subject with Atrophic Dry-AMD

04/01/2018 - Pixium Vision receives FDA approval to begin human clinical study of its PRIMA retinal implant in the US

The feasibility clinical study is designed to evaluate PRIMA sub-retinalimplant in patients with Atrophic Dry Age-related Macular Degeneration

16/02/2017 - Pixium Vision announces first implantation and activation of IRIS® II in Spain

The prestigious Institute of Ocular Microsurgery in Barcelona implanted the first patient in Spain with IRIS® II, a bionic vision system equipped with a bio-inspired camera and a 150-electrode epi-retinal implant that is designed to be explantable.

15/02/2017 - Pixium Vision appoints Didier Laurens as Chief Financial Officer

Didier Laurens joins Pixium Vision's management team and leads company's corporate financial and investor relations activities

14/02/2017 - Pixium Vision receives NUB innovation reimbursement Status-1 for 150 electrode IRIS®II bionic system in Germany

German Institute for the Hospital Remuneration System (InEK) has granted NUB (Neue Untersuchungs- und Behandlungsmethoden) Status-1 for IRIS®II, Pixium Vision's first bionic vision system, equipped with a bio-inspired camera and a 150 electrodes epi-retinal implant with a proprietary design intended to be explantable and upgradable.

22/04/2015 - Pixium Vision welcomed French Health Minister, Marisol Touraine at the

Madame Touraine was able to learn more about the progress made by Pixium Vision in the development of its vision restoration systems